Skip to main content

Advertisement

SpringerLink
Log in

Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy?

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

About 20% of patients with colorectal cancer have synchronous un-resectable liver metastases. Resection of colorectal cancer in patients with moderate-severe symptoms is mandatory before starting chemotherapy. Surgical treatment of asymptomatic colorectal cancers is still a matter of discussion.

Methods

From January 2000 to December 2004, we prospectively collected data on 35 consecutive patients who were treated straightaway by chemotherapy without primary tumor resection. All patients underwent FOLFOX6 as first-line chemotherapy. The aim of the study was to evaluate the rate of surgical complications related to un-resected colorectal tumor.

Results

The mean interval between diagnosis and start of chemotherapy was 23.1 days (95% CI: 17.3–28.8). Fifteen of the 35 patients (42.9%) were down-staged to surgery; the mean interval between chemotherapy start and colon-rectum cancer resection was 6.5 months (95% CI: 5.5–7.5). None of them developed complications related to the primary tumor during chemotherapy. Of the other 20 patients who did not undergo any curative surgery, 16 received a second line chemotherapy and 10 a third line: six patients are alive and without intestinal symptoms (mean follow up 22.5 months, 95% CI: 11.2–33.9). Only one patient (2.8%) developed clinical signs of intestinal occlusion 5.6 months from the start of chemotherapy and required urgent colostomy.

Conclusions

The rate of complications related to the non-resected colorectal tumor is very low using oxaliplatin as first line chemotherapy. Non-operative management of asymptomatic colorectal cancers with un-resectable liver metastases is a safe approach.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.

Similar content being viewed by others

References

  1. Colorectal Cancer Collaborative Group. Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. BMJ 2000; 321:531–5

    Article  Google Scholar 

  2. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al. Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 1999; 10:663–669

    Article  PubMed  CAS  Google Scholar 

  3. Joffe J, Gordon PH. Palliative resection for colorectal carcinoma. Dis Colon rectum 1981; 24:355–360

    Article  PubMed  CAS  Google Scholar 

  4. Longo WE, Ballantyne GH, Bilchik AJ, Modlin IM. Advanced rectal cancer. What is the best palliation ? Dis Colon Rectum 1988; 31:842–847

    Article  PubMed  CAS  Google Scholar 

  5. Rosen SA, Buell JF, Yoshida A, Kazsuba S, Hurst R, Michelassi F, Millis M, Posner MC. Initial presentation with stage IV colorectal cancer. How aggressive should we be? Arch Surg 2000; 135:530–535

    Article  PubMed  CAS  Google Scholar 

  6. Ruo L, Gougoutas C, Paty PB, Guillem JG, Cohen AM, Wong WD. Elective bowel resection for incurable stage IV colorectal cancer: prognostic variables for asymptomatic patients. J Am Coll Surg 2003; 196:722–728. DOI: 10.1016/S1072-7515(03)00136-4

    Article  PubMed  Google Scholar 

  7. Scoggins CR, Meszoely IM, Blanke CD, Beauchamp RD, Leach SD. Nonoperative management of primary colorectal cancer in patients with stage IV disease. Ann Surg Oncol 1999; 6:651–657

    Article  PubMed  CAS  Google Scholar 

  8. Benoist S, Pautrat K, Mitry E, Rougier P, Penna C, Nordlinger B. Treatment strategy for patients with colorectal cancer and synchronous irresectable liver metastases. Br J Surg 2005; 92:1155–1160. DOI: 10.1002/bjs.5060

    Article  PubMed  CAS  Google Scholar 

  9. Sarela AI, Guthrie JA, Seymourt MT, Ride E, Guillou PJ, O’Riordain S. Non-operative management of the primary tumour in patients with incurable stage IV colorectal cancer. Br J Surg 2001; 88:1352–1356

    Article  PubMed  CAS  Google Scholar 

  10. Therasse P, Arbuck SG, Eisenhauer E, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92:205–216

    Article  PubMed  CAS  Google Scholar 

  11. Steinberg SM, Barkin JS, Kaplan RS, Stablein DM. Prognostic indicators of colon tumors. The Gastrointestinal Tumor Study Group experience. Cancer 1986; 57:1866–1870

    Article  PubMed  CAS  Google Scholar 

  12. Finan PJ, Marshall RJ, Cooper EH, Giles GR. Factors affecting survival in patients presenting with synchronous hepatic metastases from colorectal cancer: a clinical and computer analysis. Br J Surg 1985; 72:373–7

    Article  PubMed  CAS  Google Scholar 

  13. Goslin R, Steele G Jr, Zamcheck N, Mayer R, MacIntyre J. Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon or rectum. Dis Colon Rectum 1982; 25:749–54

    Article  PubMed  CAS  Google Scholar 

  14. Bengtsson G, Carlsson G, Hafstrom L, Jonsson PE. Natural history of patients with untreated liver metastases from colorectal cancer. Am J Surg 1981; 141:586–9

    Article  PubMed  CAS  Google Scholar 

  15. Moran MR, Rothenberger DA, Lahr CJ, Buls JG, Goldberg SM. Palliation for rectal cancer. Resection? Anastomosis? Arch Surg 1987; 122:640–643

    PubMed  CAS  Google Scholar 

  16. Michel P, Roque I, Di Fiore F, Langlois S, Scotte M, Teniere P, Paillot B. Colorectal cancer with non-resectable synchronous metastases: should the primari tumor be resected? Gastroenterol Clin Biol 2004; 28:434–437

    Article  PubMed  Google Scholar 

  17. Stelzner S, Hellmich G, Koch R, Ludwig K. Factors predicting survival in stage IV colorectal carcinoma patients after palliative treatment: a multivariate analysis. J Surg Oncol 2005; 89:211–217

    Article  PubMed  Google Scholar 

  18. Tebbutt NC, Norman AR, Cunningham D, Hill ME, Tait D, Oates J, Livingstone S, Andreyev J. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut 2003; 52:568–573

    Article  PubMed  CAS  Google Scholar 

  19. de Gramont A, Figer A, Seymour M, Homerin M, Hmissi A, Cassidy J, Boni C, Cortes-Funes H, Cervantes A, Freqyer G, Papamichael D, Le Bail N, Louvet C, Hendler D, de Braud F, Wilson C, Morvan F, Bonetti A. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000; 18:2938–2947

    PubMed  Google Scholar 

  20. Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, Levitt R, Rowland K, Nair S, Sargent DJ, Donohue JH. Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 2005; 23:9243–9249. DOI: 10.1200/JCO.2005.07.740

    Article  PubMed  CAS  Google Scholar 

  21. Tournigand C, Andrè T, Achille E, Lledo G, Flesh M, Mery-Mignard D, Quinaux E, Couteau C, Buyse M, Ganem G, landi B, Colin P,Louvet C, de Gramont A. FOLFIRI follone by FOLFOX6 or the riverse sequenze in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol 2004; 22:229–237. DOI: 10.1200/JCO.2004.05.113

    Article  PubMed  CAS  Google Scholar 

  22. Cohen AM. What is the best treatment for stage IV colorectal cancer? Ann Surg Oncol 2005; 12:581–582. DOI: 10.1245/ASO.2005.03.901

    Article  PubMed  Google Scholar 

  23. Wichmann MW, Huttl TP, Winter H, Spelsberg F, Angele MK, Heiss MM, Jauch KW. Immunological effects of laparoscopic vs open colorectal surgery. Arch Surg 2005; 140:692–697

    Article  PubMed  Google Scholar 

  24. Jarnagin WR, Delman K, Kooby D, Mastorides S, Zager J, Brennan MF, Blumgart LH, Federoff H, Fong Y. Neoadjuvant interleukin-12 immunogene therapy protects against cancer recurrence after liver resection in an animal model. Ann Surg 2000; 231:762–71

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Istituto per la Ricerca e la Cura del Cancro, Candiolo (TO), Italy

    Andrea Muratore MD, Daria Zorzi MD, Hedayat Bouzari MD, Marco Amisano MD, Paolo Massucco MD & Lorenzo Capussotti MD

  2. Division of Medical Oncology, Istituto per la Ricerca e la Cura del Cancro, Candiolo (TO), Italy

    Elisa Sperti MD

  3. Via Muratori 2C, 10126, Torino, Italy

    Andrea Muratore MD

Authors
  1. Andrea Muratore MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daria Zorzi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hedayat Bouzari MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marco Amisano MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paolo Massucco MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Elisa Sperti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Lorenzo Capussotti MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Andrea Muratore MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Muratore, A., Zorzi, D., Bouzari, H. et al. Asymptomatic Colorectal Cancer with Un-Resectable Liver Metastases: Immediate Colorectal Resection or Up-Front Systemic Chemotherapy?. Ann Surg Oncol 14, 766–770 (2007). https://doi.org/10.1245/s10434-006-9146-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9146-1

Keywords

Search

Navigation